Autopsy report · NCT04649411

Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“PMR release”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 3
Sponsor: Keryx Biopharmaceuticals
Sponsor type: Industry
Conditions: Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Interventions: ferric citrate; standard of care
Participants: 0

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.